UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25
                           NOTIFICATION OF LATE FILING


                           ============================
                           SEC FILE NUMBER: 000-33167
                           ============================
                           CUSIP NUMBER:    49834X 10 6
                           ============================






(Check One): |_| Form 10-K  |_| Form 20-F  |_| Form 11-K  |X| Form 10-Q
             |_| Form N-SAR |_| Form N-CSR

For Period Ended:     March 31, 2009
                  ---------------------

             |_| Transition Report on Form 10-K
             |_| Transition Report on Form 20-F
             |_| Transition Report on Form 11-K
             |_| Transition Report on Form 10-Q
             |_| Transition Report on Form N-SAR

For the Transition Period Ended:
                                 ---------------------------------------



================================================================================
    Nothing in this form shall be construed to imply that the Commission has
                   verified any information contained herein.
================================================================================
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

PART I  --  REGISTRANT INFORMATION


Kiwa Bio-Tech Products Group Corporation
Full Name of Registrant

--------------------------------------------------------------------------------
Tintic Gold Mining Company
Former Name if Applicable

--------------------------------------------------------------------------------
310 N. Indian Hill Blvd., #702
Address of Principal Executive Office (Street and Number)

--------------------------------------------------------------------------------
Claremont, California 91711
City, State and Zip Code



PART II  --  RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

|X|   (a)   The reasons described in reasonable detail in Part III of this form
            could not be eliminated without unreasonable effort or expense;


|X|   (b)   The subject annual report, semi-annual report, transition report on
            Form 10-Q, Form 10-K, Form 20-F,11-K or Form N-SAR, or portion
            thereof, will be filed on or before the fifteenth calendar day
            following the prescribed due date; or the subject quarterly report
            of transition report on Form 10-Q, or portion thereof will be filed
            on or before the fifth calendar day following the prescribed due
            date; and

|_|   (c)   The accountant's statement or other exhibit required by Rule
            12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-Q, 10-K, 20-F, 11-K,
10-Q, N-SAR, or the transition report portion thereof, could not be filed within
the prescribed time period.

Registrant did not obtain all the necessary information prior to the filing date
and the attorney and accountant could not complete the required legal
information and financial statements and management could not complete the
Management's Discussion and Analysis of such financial statements prior to May
15, 2009.
                         (Attach Extra Sheets if Needed)

PART IV-- OTHER INFORMATION

(1)   Name and telephone number of person to contact in regard to this
      notification

            Yvonne Wang                 909                 626-2358
            --------------------------------------------------------------------
               (Name)               (Area Code)        (Telephone Number)

(2)   Have all other periodic reports required under Section 13 or 15(d) of the
      Securities Exchange Act of 1934 or Section 30 of the Investment Company
      Act of 1940 during the preceding 12 months or for such shorter period that
      the registrant was required to file such report(s) been filed? If answer
      is no, identify report(s).

                                                                  Yes |X| No |_|

(3)   Is it anticipated that any significant change in results of operations
      from the corresponding period for the last fiscal year will be reflected
      by the earnings statements to be included in the subject report or portion
      thereof?

                                                                  Yes |_| No |X|

If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.





                    Kiwa Bio-Tech Products Group Corporation
                  (Name of Registrant as Specified in Charter)


has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.


Date:   May 15, 2009                      By:   /s/ Wei Li
                                                -----------------------
                                                Chief Executive Officer